Actively Recruiting
Efficacy and Safety of Auto-FMT in Preventing aGVHD
Led by The First Affiliated Hospital of Soochow University · Updated on 2025-12-31
100
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluation the efficacy and safety of autologous fecal bacteria transplantation in preventing acute graft versus host disease after haploidentical hematopoietic stem cell transplantation. Bone marrow transplant patients were recruited.
CONDITIONS
Official Title
Efficacy and Safety of Auto-FMT in Preventing aGVHD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must be undergoing haploidentical hematopoietic stem cell transplantation (haplo-HSCT)
- Bacteroidetes level greater than 0.1%
- Inverse Simpson diversity index of 2 or higher
- Age between 18 and 60 years
You will not qualify if you...
- Presence of gastrointestinal diseases
- Age greater than 60 years or less than 10 years
- Use of probiotics or prebiotics before enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ye Zhao
Suzhou, Jiangsu, China, 215006
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here